NASAL LOTION SPRAY MARKET ANALYSIS

Nasal Lotion Spray Market, By Product Type (Saline Solution, Steroid Nasal Sprays, Antihistamine Nasal Sprays, Decongestant Nasal Sprays, Natural/Organic Nasal Sprays and Others (Oxymetazoline, Phenylephrine and Others)), By Application (Allergy Relief, Sinusitis Treatment, Cold & Flu Relief, Hay Fever Relief and Others (Nasal dryness & itch relief and Others), By Age Group (Adults, Children, and Infants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce and Others (Hypermarkets, Convenience Stores, among others)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

New product launches

On January 30, 2023, Aptar Pharma, a part of AptarGroup, Inc. and provider of drug delivery systems, services and active material science solutions, launched the APF Futurity, its first metal-free, multidose nasal spray pump that is developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations
In 2021, Cipla Limited, a India-based multinational pharmaceutical company launched Naselin antiviral nasal spray with Povidone Iodine that can offer the first line of defence against the COVID-causing SARS-CoV-2 virus

Acquisition and partnerships

In 2019, Hikma Pharmaceuticals PLC, a U.K. based multinational pharmaceutical company, announced that it has signed an asset purchase agreement with Insys Therapeutics Inc., a U.S. based specialty pharmaceutical company, in order to acquire unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products, naloxone 505(b)2 nasal spray and epinephrine 505(b)2 nasal spray